New Key Statistics Module, Z-Score and F-Score
SZSE:300267 Key Ratios
| Market Cap ¥ M | 5,548.41 |
| Enterprise Value ¥ M | 5,213.86 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.19 |
| Price/Sales | 4.16 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) ¥ M | 1,354.00 |
| EPS (TTM) ¥ | -0.12 |
| Beneish M-Score | -3.02 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -700.00 |
| EV-to-EBIT | -22.13 |
| EV-to-EBITDA | -22.13 |
| PEG | -- |
| Shares Outstanding M | 2,062.60 |
| Net Margin (%) | -17.79 |
| Operating Margin % | -8.32 |
| Pre-tax Margin (%) | -18.01 |
| Quick Ratio | 1.71 |
| Current Ratio | 2.89 |
| ROA % (ttm) | -4.38 |
| ROE % (ttm) | -4.89 |
| ROIC % (ttm) | -2.53 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.85 |
SZSE:300267 Number of Guru Trades
SZSE:300267 Volume of Guru Trades
Gurus Latest Trades with SZSE:300267
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300267 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hunan Er-Kang Pharmaceutical Co Ltd Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers